These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33895924)

  • 81. Effect of the mycotoxin, penicillic acid, on Tetrahymena pyriformis.
    Hayes AW
    Toxicon; 1977; 15(6):497-504. PubMed ID: 410118
    [No Abstract]   [Full Text] [Related]  

  • 82. Relationships of quantitative structure-activity to comparative toxicity of selected phenols in the Pimephales promelas and Tetrahymena pyriformis test systems.
    Schultz TW; Holcombe GW; Phipps GL
    Ecotoxicol Environ Saf; 1986 Oct; 12(2):146-53. PubMed ID: 3098546
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Toxicity profiles of four metals and 17 xenobiotics in the human hepatoma cell line HepG2 and the protozoa Tetrahymena pyriformis--a comparison.
    Rudzok S; Krejči S; Graebsch C; Herbarth O; Mueller A; Bauer M
    Environ Toxicol; 2011 Apr; 26(2):171-86. PubMed ID: 19790250
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.
    Joseph MM; Aravind SR; George SK; Raveendran Pillai K; Mini S; Sreelekha TT
    Eur J Pharm Biopharm; 2015 Jun; 93():183-95. PubMed ID: 25864443
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dual effects of quercetin in doxorubicin-induced nephrotoxicity in rats and its modulation of the cytotoxic activity of doxorubicin on human carcinoma cells.
    Heeba GH; Mahmoud ME
    Environ Toxicol; 2016 May; 31(5):624-36. PubMed ID: 25411067
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Structure-toxicity relationships for phenols to Tetrahymena pyriformis.
    Cronin MT; Schultz TW
    Chemosphere; 1996 Apr; 32(8):1453-68. PubMed ID: 8653384
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Exceptional release kinetics and cytotoxic selectivity of oxidised MWCNTs double-functionalised with doxorubicin and prostate-homing peptide.
    Milosavljevic V; Krejcova L; Guran R; Buchtelova H; Wawrzak D; Richtera L; Heger Z; Kopel P; Adam V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():123-132. PubMed ID: 28527356
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of butylated hydroxyanisole on Tetrahymena pyriformis.
    Surak JG; Bradley RL; Branen AL; Shrago E
    Food Cosmet Toxicol; 1976 Aug; 14(4):277-81. PubMed ID: 824187
    [No Abstract]   [Full Text] [Related]  

  • 90. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structural reorganization of the rat liver under cytotoxic effect of doxorubicin.
    Molodykh OP; Lushnikova EL; Klinnikova MG; Nepomnyashchikh LM
    Bull Exp Biol Med; 2006 May; 141(5):639-44. PubMed ID: 17181073
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 93. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 94. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
    Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
    Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Linear versus nonlinear QSAR modeling of the toxicity of phenol derivatives to Tetrahymena pyriformis.
    Devillers J
    SAR QSAR Environ Res; 2004 Aug; 15(4):237-49. PubMed ID: 15370415
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
    Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
    Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Monotertiarybutylhydroquinone effects on Tetrahymena pyriformis.
    Surak JG
    Life Sci; 1977 May; 20(10):1735-40. PubMed ID: 406489
    [No Abstract]   [Full Text] [Related]  

  • 98. Model-based QSAR for ionizable compounds: toxicity of phenols against Tetrahymena pyriformis.
    Pirselová K; Baláz S; Schultz TW
    Arch Environ Contam Toxicol; 1996 Feb; 30(2):170-7. PubMed ID: 8593079
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
    Nagy A; Schally AV; Armatis P; Szepeshazi K; Halmos G; Kovacs M; Zarandi M; Groot K; Miyazaki M; Jungwirth A; Horvath J
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7269-73. PubMed ID: 8692981
    [TBL] [Abstract][Full Text] [Related]  

  • 100. New Plant Species Showing Antiprotozoian Activity.
    Cheremnykh EG; Osipov AV; Starkov VG; Trang NTT; Khoa NC; Anh HN; Dung LT; Tsetlin VI; Utkin YN
    Dokl Biochem Biophys; 2022 Dec; 507(1):334-339. PubMed ID: 36786997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.